Role of sclerostin in the bone loss of postmenopausal Chinese women with type 2 diabetes

Chinese Medical Sciences Journal

Volumn 28, Issue 3, 2013, Pages 135-139

  Zhou, Yi Jun ^a   Li, Ai ^a   Song, Yu Ling ^a   Zhou, Hui ^a   Li, Yan ^a   Tang, Yin Si ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

bone markers; bone mineral density; postmenopause; sclerostin; type 2 diabetes mellitus

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; COLLAGEN TYPE 1; ESTRADIOL; HEMOGLOBIN A1C; PARATHYROID HORMONE; SCLEROSTIN;

ADULT; AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DUAL ENERGY X RAY ABSORPTIOMETRY; ELISA KIT; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HEMOGLOBIN BLOOD LEVEL; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE;

AGED; ALKALINE PHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; HEMOGLOBIN A; HUMANS; MIDDLE AGED; OSTEOCYTES; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; RETROSPECTIVE STUDIES;

EID: 84885602688     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(13)60038-3     Document Type: Article

References (15)

1. KE Poole, RL van Bezooijen, N Loveridge et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation FASEB J 19 2005 1842 1844
2. MJ Moester, SE Papapoulos, CW Löwik et al. Sclerostin: Current knowledge and future perspectives Calcif Tissue Int 87 2010 99 107
3. E Terpos, K Fragiadaki, M Konsta et al. Early effects of IL-6 receptor inhibition on bone homeostasis: A pilot study in women with rheumatoid arthritis Clin Exp Rheumatol 29 2011 921 925
4. D Cejka, J Herberth, AJ Branscum et al. Sclerostin and Dickkopf-1 in renal osteodystrophy Clin J Am Soc Nephrol 6 2011 877 882
5. D Cejka, A Jäger-Lansky, H Kieweg et al. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients Nephrol Dial Transplant 27 2012 226 230
6. UI Mödder, KA Hoey, S Amin et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men J Bone Miner Res 26 2011 373 379
7. FS Mirza, ID Padhi, LG Raisz et al. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women J Clin Endocrinol Metab 95 2010 1991 1997
8. A García-Martín, P Rozas-Moreno, R Reyes-García et al. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 97 2012 234 241
9. L Gennari, D Merlotti, R Valenti et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes J Clin Endocrinol Metab 97 2012 1737 1744
10. M McNulty, RJ Singh, X Li et al. Determination of serum and plasma sclerostin concentrations by enzymelinked immunoassays J Clin Endocrinol Metab 96 2011 E1159 E1162
11. A Saller, S Maggi, G Romanato et al. Diabetes and osteoporosis Aging Clin Exp Res 20 2008 280 289
12. UI Mödder, JA Clowes, K Hoey et al. Regulation of circulating sclerostin levels by sex steroids in women and in men J Bone Miner Res 26 2010 27 34
13. SA Polyzos, AD Anastasilakis, C Bratengeier et al. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women - the six-month effect of risedronate and teriparatide Osteoporos Int 23 2012 1171 1176
14. AH van Lierop, JE Witteveen, NA Hamdy et al. Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls Eur J Endocrinol 163 2010 833 837
15. I Bergström, P Parini, SA Gustafsson et al. Physical training increases osteoprotegerin in postmenopausal women J Bone Miner Metab 30 2012 202 207